Jane Street’s Impact BioMedical IBO Stock Holding History
Bought
Maintained
Sold
Other funds holding IBO
Jane Street's IBO Position: Q3 2026 in Review
Jane Street sold out of Impact BioMedical (IBO) in Q3 2026, closing a stake of 1,944 shares — an estimated $11.3K sold.
Jane Street first reported a position in IBO in Q3 2024 and held it in 3 quarters. The position peaked at $26.7K in Q3 2024. 19 funds tracked by Wall St. Rank hold IBO as of Q3 2026.
- Jane Street reported no remaining Impact BioMedical position as of Q3 2026 after selling out during the quarter.
- Jane Street sold 1,944 Impact BioMedical shares in Q3 2026, an estimated $11.3K.
- Jane Street first reported a position in Impact BioMedical in Q3 2024 and held it in 3 quarters.
- Jane Street's Impact BioMedical position peaked at $26.7K in Q3 2024.
- 19 funds tracked by Wall St. Rank held Impact BioMedical as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.